The identification of 3-phosphoinositide-dependent kinase 1 (PDK1) as one of the elusive 70 kDa S6 kinase kinases has filled a gap in the signaling pathway by which extracellular receptors regulate translation. Will it cause us to reconsider the relationships between previously identified members of the pathway?
To promote cell division effectively, mitogens must upregulate translation. Phorbol esters, growth factors, cytokines and oncogene products all signal to the translational machinery, calling for increased translation. One of the master translational switches upon which these signals converge is the 70 kDa S6 kinase (p70 S6K ) [1] . Phosphorylation of the ribosomal subunit S6 by p70 S6K correlates with increased translation, especially of mRNAs containing a polypyrimidine tract in their 5′ untranslated regions [2] . This family of mRNAs includes members thought to be important for cell-cycle progression. The prominent role of p70 S6K in mitogenesis may thus be due, at least in part, to its ability to promote the general translation necessary for growth and division, and to generate specifically many of the molecules necessary for driving the cell cycle. Inactivation of p70 S6K , either by injection of neutralizing antibodies [3] or by treatment with the natural product rapamycin [1] , has the opposite effect, causing G1 cellcycle arrest in many cell types.
The kinase p70 S6K was identified and cloned nearly a decade ago. In the years since then, many of the details of p70 S6K activation have been revealed, including the identity of potential upstream signaling moleculesphosphatidylinositol 3-kinase (PI 3-K), protein kinases B and C (PKB and PKC), phospholipase Cγ (PLCγ), Rac1 and Cdc42. Together, these proteins mediate a signaling pathway distinct from the well-characterized mitogen activated protein (MAP) kinase pathway [1] . In addition, at least nine phosphorylation sites on p70 S6K have been mapped, and their roles in the sequential activation of p70 S6K have been studied meticulously. It appears that activation involves phosphorylation of the proline-directed sites in the carboxy-terminal tail of p70 S6K , followed by phosphorylation of Thr389 and Ser404, and finally phosphorylation of Thr229 to yield a fully active kinase [4] .
Despite the importance of these phosphorylation sites, until very recently none of the kinases that phosphorylate p70 S6K in vivo had been identified. Two recent papers [5, 6] have identified what may be the first of the elusive S6 kinase kinases -the recently cloned 3-phosphoinositide-dependent protein kinase 1 (PDK1).
PDK1 was isolated and cloned during the past year on the basis of its ability to phosphorylate PKB [7, 8] . PKB is the cellular homolog of the protein encoded by the viral oncogene v-akt, and has been shown to have roles in serummediated cell survival and insulin-mediated glucose uptake and glycogen synthesis (reviewed in [9] ). PKB's principal means of activation seems, like that of p70 S6K , to be through PI 3-K. Both kinases are activated by constitutively active mutants of PI 3-K, and are inhibited by a dominant-negative form of PI 3-K or small-molecule PI 3-K inhibitors, such as wortmanin or LY294002 [1, 9] . Consistent with the idea that PDK1 activates PKB in response to PI 3-K activity, PDK1's ability to phosphorylate and activate PKB in vitro is highly dependent upon the presence of phospholipids generated by PI 3-K, either phosphatidylinositol 3,4-bisphosphate (PIP 2 ) or phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ). Adding vesicles containing these phospholipids to in vitro kinase assays increases PDK1's ability to phosphorylate PKB by as much as one thousandfold [7] .
Although PKB and p70 S6K differ structurally, their sequences are remarkably similar in regions surrounding their most critical phosphorylation sites. The activation loop phosphorylation sites Thr308 in PKB and Thr229 in p70 S6K both lie within the sequence T(p)FCGTXEY -where (p) is phosphate, X is a nonconserved residue and other letters follow the singleletter amino-acid code -and both kinases possess a critical phosphorylation site immediately carboxy-terminal to the kinase domain, within the motif FXXFS/T(p)YXA. Prompted by these similarities, Alessi et al. [5] and Pullen et al. [6] sought to determine whether PDK1, the enzyme that phosphorylates PKB on residue Thr308, is also responsible for phosphorylating the corresponding activation loop of p70 S6K .
Using purified, recombinant forms of PDK1 and p70 S6K , Alessi et al. [5] and Pullen et al. [6] demonstrated that PDK1 specifically phosphorylates p70 S6K at residue Thr229 in vitro. As might have been predicted by previously defined models of sequential p70 S6K activation [4] , this in vitro phosphorylation at Thr229 was most pronounced when p70 S6K had been disinhibited, either by truncation of its autoinhibitory carboxy-terminal tail [5] , or by mutation of the proline-directed phosphorylation sites in the carboxy-terminal tail to acidic residues [6] . Substituting Thr389 with glutamate also increased the extent of p70 S6K phosphorylation by PDK1. In vitro phosphorylation of Thr229 by PDK1 resulted in increased p70 S6K activity, as assayed by S6 phosphorylation. This activation was weak [5] or non-existent [6] with wild-type p70 S6K , but was substantial when the disinhibited p70 S6K mutants were used [5, 6] .
In vivo studies added further credence to the idea that PDK1 is an S6 kinase kinase. Co-expression of PDK1 and p70 S6K resulted in modest activation of full-length p70 S6K in vivo. Cotransfection of cells with constructs encoding PDK1 and the disinhibited p70 S6K mutants resulted in a strong increase in p70 S6K activity, which could not be further augmented by insulin and was comparable to the activation achieved on cotransfection with constructs encoding p70 S6K and activated forms of PI 3-K or PKB [5, 6] . Furthermore, expression of a kinase-dead PDK1 mutant prevented insulin from activating p70 S6K [6] . Together, these results suggest that PDK1 lies on the pathway leading to p70 S6K activation.
Because p70 S6K and PKB both lie downstream from PI 3-K and are phosphorylated by PDK1, it might be tempting to think that PDK1 serves as a point of bifurcation in the PI 3-K pathway, activating PKB and p70 S6K by the same mechanism in response to PIP 2 or PIP 3 production (Figure 1 ). For such a model to hold, one incongruent result must be justified. Alessi et al. [5] found that, in contrast to phosphorylation of PKB by PDK1, phosphorylation of p70 S6K by PDK1 in vitro is unaffected by the presence of phospholipids. Phosphorylation of p70 S6K by PDK1 was dependent only upon the state of the autoinhibitory tail and Thr389 of p70 S6K , with phosphorylation occurring most readily when Thr389 is phosphorylated and the autoinhibitory carboxy-terminal tail is phosphorylated or removed.
Because PI 3-K-generated phospholipids do not activate PDK1's kinase activity towards p70 S6K in vitro, by what mechanism does PI 3-K achieve activation of p70 S6K , and how does this mechanism differ from that leading to activation of PKB? Both PKB and PDK1 contain pleckstrin homology (PH) domains that bind with high affinity to PIP 2 and PIP 3 . Deletion of the PH domain from either protein greatly diminishes the extent of PKB phosphorylation, although deletion of PDK1's PH domain does not abolish the lipid-dependence of PDK1-mediated PKB phosphorylation [7] . These experiments suggest that PI 3-K-generated phospholipids facilitate PKB phosphorylation in part by binding to the autoinhibitory PH domain of PKB and increasing the access of PDK1 to Thr308.
A more prominent effect of the phospholipids appears to be recruitment of PDK1 and PKB to the membrane (or lipid vesicles in vitro), where their increased proximity to one another facilitates phosphorylation. If p70 S6K , which does not possess a PH domain, is also regulated by controlling its proximity to PDK1, it must have some other means of being recruited to PDK1-containing membranes. It has been suggested [5] that this may occur through Rac1 and/or Cdc42, members of the Rho family of small GTPases that localize to membranes through their isoprenyl moieties and have been shown to bind to p70 S6K and to be required for its activation in vivo [10] . In the in vitro kinase assays performed by Alessi et al. [5] , such GTPases would not have been present, preventing localization of p70 S6K to the vesicles and rendering PDK1's activity insensitive to lipid activation.
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Figure 1
A model depicting how PDK1 may mediate a mitogen-induced increase in translation. PDK1 activates PKB by phosphorylation at Thr308 when the two proteins are recruited to the membrane in response to PIP 3 production. By analogy, p70 S6K may be activated when PDK1 phosphorylates it on Thr229 after recruitment to the membrane, which in the case of p70 S6K may be mediated by active forms of the small GTPases Rac1 and/or Cdc42. GSK3, glycogen synthase kinase 3; GLUT4, glucose transporter 4; FRAP, FK506-binding protein-rapamycin associated protein. Alternative mechanisms of p70 S6K activation can be imagined that do not require membrane recruitment. For example, PDK1 may be constitutively active, with access to residue Thr229 of p70 S6K being controlled by phosphorylation of Thr389 or the carboxy-terminal tail by a different PI 3-K-dependent kinase. Cotransfection of cells with constructs encoding p70 S6K and a deletion mutant of PDK1 lacking the PH domain, or experiments that artificially localize p70 S6K to the membrane, may reveal whether p70 S6K activation occurs by increasing its proximity to PDK1 or by some other means. The existence of a direct link between PDK1 and p70 S6K has raised other questions. For instance, how do activated forms of PKB, such as myristoylated PKB, activate p70 S6K if the two are on parallel pathways downstream of PDK1? Is there a feedback loop from PKB which activates PDK1 toward p70 S6K , or does PKB activate p70 S6K via phosphorylation of Thr389? Another possibility is that PKB and p70 S6K associate so that myristoylated PKB recruits p70 S6K to membranes where it can be phosphorylated by PDK1.
Another intriguing finding is that PDK1 contains a phosphorylation site within a region similar to its own consensus target sequence [7] (Figure 2 ). This motif has now been identified in the activation loop of several members of the p70 S6K signaling pathway, including p70 S6K , PKB, PKC and PDK1 (it is also found in several kinases with no known link to the pathway). Curiously, a similar motif also occurs in FRAP, a member of the phosphatidylinositol kinase (PIK)-related kinase family, outside its kinase domain and near its carboxy-terminal tail (Figure 2) . FRAP mediates the rapid dephosphorylation and inactivation of p70 S6K induced by rapamycin [11] . Is PDK1 involved in this process? Some evidence suggests that the principal rapamycin-sensitive site in p70 S6K is Thr389, rather than Thr229 [2] . Furthermore, PKB appears to be insensitive to rapamycin [12] , and Pullen et al. [6] have now shown that in vitro PDK1 activity is insensitive to pretreatment with rapamycin. While this evidence argues against a role for PDK1 in the rapamycin response, the frequent appearance of this motif is difficult to ignore.
Are all of these proteins with consensus target sequences physiological PDK1 substrates, or do they share a common phosphatase that acts at multiple levels to deactivate the pathway? Perhaps this motif is recognized by a scaffolding protein that facilitates signaling by bringing components of the pathway together. Whatever the reason for this shared phosphorylation motif, it may play a key role in governing the pathway that links extracellular signals to translation regulation. Finding answers to these outstanding questions regarding PDK1's role in p70 S6K signaling is a necessary step toward understanding how cell proliferation is controlled. PDK1 target motifs in members of the p70 S6K pathway, grouped to emphasise points mentioned in the text. In the first four cases, the sequence occurs in the enzyme's kinase domain activation loop; in the case of FRAP, the sequence lies outside of its kinase domain, in a region of unknown function. Green, residues identical in all five proteins; blue, residues conserved in all five proteins; pink, residues identical within a subgroup; yellow, residues conserved within a subgroup; phosphorylation sites are indicated by an asterisk. 
